Cargando…
N-acetylcysteine for non-acetaminophen induced acute liver failure: A review
The use of N-acetylcysteine (NAC) for non-acetaminophen-induced acute liver failure (NAI-ALF) has been increasing despite controversy in its efficacy. National guidelines are in disagreement for NAC use as standard of care; however, many healthcare centers continue to adopt the use of NAC outside of...
Autores principales: | Jiang, Shirley Xue, Hussaini, Trana, Yoshida, Eric M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007071/ https://www.ncbi.nlm.nih.gov/pubmed/35142656 http://dx.doi.org/10.4103/sjg.sjg_406_21 |
Ejemplares similares
-
Impact of Duration of N-Acetylcysteine in Non-Acetaminophen–Induced Acute Liver Failure
por: Bass, Stephanie N., et al.
Publicado: (2021) -
The role of N-acetylcysteine in the treatment of non-acetaminophen acute liver failure
por: Teriaky, Anouar
Publicado: (2017) -
Role of N-acetylcysteine treatment in non-acetaminophen-induced acute liver failure: A prospective study
por: Nabi, Tauseef, et al.
Publicado: (2017) -
Use of Oral N-Acetylcysteine (NAC) in Non-Acetaminophen-Induced Acute Hepatic Failure
por: Sharieff, Saleem, et al.
Publicado: (2023) -
N-acetylcysteine in non-acetaminophen-induced acute liver failure: a systematic review and meta-analysis of prospective studies
por: Amjad, Waseem, et al.
Publicado: (2021)